Home Diagnostics Market Demand And Trends Till 2021

Demand for home healthcare products has increased dramatically in the recent past. Home diagnostic test kits are becoming popular globally, and are altering patient path. With these test kits, patients can perform primary diagnosis at home, and decide for further plan of action for confirmed disease diagnosis treatment. Home diagnostics tests are low cost alternatives to subvert time consuming and expensive trip to a physician. These tests provide results in short period of time, and do not require laboratory setup or technical knowledge for analyze results. These convenient tests can be performed privately, thus avoid complications sue to late disease diagnosis. This has been a major merit for diagnosis of sexually transmitted diseases (STDs) and pregnancy, where teenagers are reluctant to visit physicians. Due to these factors, the home diagnostics market is growing rapidly.

Home diagnostic kits are available for infectious disease testing, substance abuse testing, pregnancy testing, blood glucose testing, allergy testing and others. Product portfolio in the home diagnostics market is currently increasing gradually due to advances in biotechnology research revealing key surface markers and other biomarkers playing important role in disease progression. In April 2015, Buhlmann Laboratories a German company New Home Test Kit Launched for Crohn's and Ulcerative Colitis. Later in 2016, SwimCount a Danish company launched sperm testing kit to measure count as well as quality of sperms. These innovative products would be the driving factors for home diagnostics market.

Request Free Report Sample@ http://www.sa-brc.com/Global-Home-Diagnostics-Market-Assessment--Forecast-2017-2021/up123

According to Clinical Laboratory Improvement Amendments of 1988 (CLIA) certain FDA cleared tests are waived which include home use tests and tests approved for waiver under the CLIA criteria. By the CLIA law, waived tests are those tests that are determined by CDC or FDA to be simple enough that there is little risk of error. Glucose detection, cholesterol detection, pregnancy tests, and various other tests are waived; currently, more than 40 tests have been approved for certificate of waiver. This has also provided necessary leverage for the market to grow in the U.S. North America currently accounts for largest market share in the home diagnostics market. High medical treatment cost and complex insurance procedures provokes more number of patients to opt for home diagnostic test kits. The trend for home diagnostics is increasing rapidly in the Asia Pacific region. Although currently pregnancy testing segment accounts for largest share, other prominent segments include diabetes testing, and infectious disease testing with major focus on HIV and Hepatitis testing.

Key players in the home diagnostics market include Alere, Inc., Abbott Laboratories, Danaher Corporation, BioRad Laboratories, Roche Diagnostics, Becton Dickinson & Company, Zoetis, Inc. and various others.

Request For TOC@ http://www.sa-brc.com/Global-Home-Diagnostics-Market-Assessment--Forecast-2017-2021/upcomingdetail123

NOTE: This report is currently under research and will be made available to clients on request.